Hoth Therapeutics (HOTH) said Wednesday its board approved the purchase of up to $1 million in bitcoin.
"As bitcoin continues to grow, gaining investor attention and acceptance as a major and primary asset class, we believe that bitcoin will serve as a strong treasury reserve asset," Hoth Chief Executive Robb Knie said.
The biopharmaceutical company's shares were up 7.3% in recent trading.
Price: 0.88, Change: +0.06, Percent Change: +7.33